These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 2273963)

  • 101. Hemophan versus hemophan--a philippic against the suggestion of constant membrane quality.
    Kolb G; Müller T; Höffken H; Joseph K; Lange H; Havemann K
    Biomater Artif Cells Immobilization Biotechnol; 1992; 20(5):1233-48. PubMed ID: 1333828
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Identifying toxic degradation products in cellulose acetate dialyzers.
    Lucas AD; Kalson JA; Hutter JC; Wallis RR
    J Biomed Mater Res; 2000 Sep; 53(5):449-56. PubMed ID: 10984691
    [TBL] [Abstract][Full Text] [Related]  

  • 103. [Dissociation between leukopenia and hypoxemia during hemodialysis].
    Faro S; Romaldini H; Stabile C; dos Santos ML
    Rev Paul Med; 1985; 103(6):284-9. PubMed ID: 3841968
    [No Abstract]   [Full Text] [Related]  

  • 104. Solute removal efficiency and biocompatibility of the high-performance membrane - from engineering points of view.
    Sakai K; Matsuda M
    Contrib Nephrol; 2011; 173():11-22. PubMed ID: 21865771
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Effect of first and subsequent use of hemodialyzers on patient well-being. Analysis of the incidence of symptoms and events and description of a syndrome associated with new dialyzer use.
    Robson MD; Charoenpanich R; Kant KS; Peterson DW; Flynn J; Cathey M; Pollak VE
    Am J Nephrol; 1986; 6(2):101-6. PubMed ID: 2939720
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Biocompatibility and the clinical choice of dialysis membranes.
    Mujais SK; Ivanovich P; Bereza LA; Vidovich M
    Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716
    [No Abstract]   [Full Text] [Related]  

  • 107. Hemodialysis membrane biocompatibility--does it matter?
    Jacobson SH
    Scand J Urol Nephrol; 1999 Apr; 33(2):83-8. PubMed ID: 10360446
    [No Abstract]   [Full Text] [Related]  

  • 108. Protein adsorption on dialyzer membranes influences their biocompatibility properties.
    Kuwahara T; Markert M; Wauters JP
    Contrib Nephrol; 1989; 74():52-7. PubMed ID: 2562019
    [No Abstract]   [Full Text] [Related]  

  • 109. In vitro clearance and hemocompatibility assessment of ultrathin nanoporous silicon membranes for hemodialysis applications using human whole blood.
    Ahmadi M; Gorbet M; Yeow JT
    Blood Purif; 2013; 35(4):305-13. PubMed ID: 23920150
    [TBL] [Abstract][Full Text] [Related]  

  • 110. [Disorders of the respiratory function in patients with chronic renal failure treated by hemodialysis. II. Evaluation of pulmonary gas exchange and hemodialysis-related leukopenia].
    Wanic-Kossowska M
    Pol Arch Med Wewn; 1987 Oct; 78(4):223-9. PubMed ID: 3271301
    [No Abstract]   [Full Text] [Related]  

  • 111. Arachidonic acid metabolites as biocompatibility parameters for cellulosic membranes.
    Boran M; Bozdayi M; Cetin S
    Nephrol Dial Transplant; 1999 Jul; 14(7):1804-5. PubMed ID: 10435906
    [No Abstract]   [Full Text] [Related]  

  • 112. Reactions to Synthetic Membranes Dialyzers: Is there an Increase in Incidence?
    Martin-Navarro J; Esteras R; Castillo E; Carriazo S; Fernández-Prado R; Gracia-Iguacel C; Mas Fontao S; Ortíz A; González-Parra E
    Kidney Blood Press Res; 2019; 44(5):907-914. PubMed ID: 31505506
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Serum angiotensin-converting enzyme is not an indicator of dialyzer membrane biocompatibility.
    Docci D; Turci F; Baldrati L; Delvecchio C
    Nephron; 1988; 48(4):335. PubMed ID: 2834657
    [No Abstract]   [Full Text] [Related]  

  • 114. The role of dialyzer biocompatibility in acute renal failure.
    Vanholder R; De Vriese A; Lameire N
    Blood Purif; 2000; 18(1):1-12. PubMed ID: 10686437
    [No Abstract]   [Full Text] [Related]  

  • 115. The effect of dialysate temperature on haemodialysis leucopenia.
    Enia G; Catalano C; Pizzarelli F; Creazzo G; Zaccuri F; Mundo A; Iellamo D; Maggiore Q
    Proc Eur Dial Transplant Assoc Eur Ren Assoc; 1985; 21():167-72. PubMed ID: 3991497
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Hydraulic and flow dynamic characteristics of PMMA dialyzers.
    Brendolan A; Ronco C; Ghezzi PM; Scabardi M; La Greca G
    Contrib Nephrol; 1999; 125():41-52. PubMed ID: 9895429
    [No Abstract]   [Full Text] [Related]  

  • 117. Leukocyte overshoot: a new sign of bioincompatibility in fast hemodialysis.
    Kjellstrand P; Jacobson SH; Skröder R; Holmquist B; Boberg U; Lins LE; Okmark P; Kjellstrand CM
    ASAIO Trans; 1990; 36(3):M314-6. PubMed ID: 2252687
    [TBL] [Abstract][Full Text] [Related]  

  • 118. The impact of dialyzers on the anaemia of haemodialysis patients.
    Fourtounas C; Kopelias I; Dimitriadis G; Agroyannis B
    Nephrol Dial Transplant; 2001 May; 16(5):1077-8. PubMed ID: 11328925
    [No Abstract]   [Full Text] [Related]  

  • 119. Dialyzer First Use Reaction with Polysulfone Membrane: Moving Beyond Ethylene Oxide.
    Tharakan A
    Indian J Nephrol; 2021; 31(4):398-401. PubMed ID: 34584359
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Dialysis-induced hypoxemia.
    Vaziri ND
    Int J Artif Organs; 1982 Jan; 5(1):8-10. PubMed ID: 7068267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.